KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Cash from Financing Activities (2016 - 2026)

Encompass Health (EHC) has disclosed Cash from Financing Activities for 18 consecutive years, with -$102.5 million as the latest value for Q1 2026.

  • For Q1 2026, Cash from Financing Activities rose 21.4% year-over-year to -$102.5 million; the TTM value through Mar 2026 reached -$403.3 million, up 4.07%, while the annual FY2025 figure was -$431.2 million, 30.43% down from the prior year.
  • Cash from Financing Activities hit -$102.5 million in Q1 2026 for Encompass Health, down from -$97.4 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at -$16.5 million in Q4 2022 and bottomed at -$150.9 million in Q4 2024.
  • Average Cash from Financing Activities over 5 years is -$71.0 million, with a median of -$60.9 million recorded in 2022.
  • Year-over-year, Cash from Financing Activities surged 89.65% in 2022 and then tumbled 404.68% in 2024.
  • Encompass Health's Cash from Financing Activities stood at -$16.5 million in 2022, then tumbled by 81.21% to -$29.9 million in 2023, then crashed by 404.68% to -$150.9 million in 2024, then soared by 35.45% to -$97.4 million in 2025, then decreased by 5.24% to -$102.5 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at -$102.5 million, -$97.4 million, and -$113.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.